The way a drug works and what it targets in the body are key factors in how effectively it can kill harmful cells. This work looks at a group of important proteins called receptor tyrosine kinases, which are often involved in diseases like cancer. Scientists have found that certain chemical structures—called heterocycles, such as pyrimidine, thiazole, imidazole, indole, acridone, and triazine—can be used to make drugs that target these proteins. With some changes, these compounds could also be designed to affect other disease pathways in the future.
